More recently, GR activation has been observed in breast cancer metastases and was associated with a GR activation signature which included genes such as MELK, CDK1, and particularly the ROR1 kinase, which may mediate resistance to chemotherapeutic agents and increase colonization [43]. This evidence concerns the gene NR3C1 and breast carcinoma.